Not available
NCT04538157
Not available
The GOAL trial addresses patient-prioritised research topics and outcomes and will be conducted, disseminated and implemented in partnership with patients and their caregivers. This will be the first study, internationally, to evaluate the clinical and cost effectiveness of Comprehensive Geriatric Assessment (CGA), a highly promising intervention for improving patient-important health outcomes in frail older people with Chronic Kidney Disease (CKD).
Inclusion Criteria for screening: * Moderate to severe CKD as determined by the treating nephrologist: * Stage 3 = eGFR 30 - 59 ml/min/1.73 m2 * Stage 4 = eGFR 15 - 29 ml/min/1.73 m2 * Stage 5/5D = eGFR below 15 ml/min/1.73m2, including patients receiving dialysis * Aged =65 years, or = 55 years if Aboriginal or Torres Strait Islander For inclusion in enrolment: * Frailty Index >0.25 (FI-CKD tool) Exclusion Criteria: * Estimated life expectancy of less than 12 months. * Unable to provide informe .... Read more
No
Sample Size Not Available
Min. age 55 Years
Max. age N/A
Sex All
Condition category Goal Attainment Scaling , Frailty Index
Condition code Frailty , Chronic Kidney Diseases
Intervention code Other interventions - Comprehensive Geriatric Assessment
Comprehensive Geriatric Assessment Experimental Specialist co-ordinated care (known as comprehensive geriatric assessment, or CGA) was developed to address medical, social, mental health, and physical needs with the help of a skilled multi-disciplinary team. Usual Care No intervention Usual Care Other interventions: Comprehensive Geriatric Assessment A CGA is a diagnostic and therapeutic intervention which initially identifies an older person's medical, functional, psychosocial problems and then .... Read more
Control group Not available
Comparison not available.
Not Available
Yes
STUDY_PROTOCOL,SAP
Beginning 2 years and ending 5 years following main publication. Proposals may be submitted up to 5 years following article publication. After 5 years, the data will be available in our University's data warehouse but without investigator support other than deposited metadata.
An independent review board will assess proposals based on the following criteria: sound science, benefit-risk balancing and research team expertise.
_
To assist secondary data users in understanding the real-world impact of health and medical research data sharing, the Australian Research Data Commons (ARDC) has created an online guide that outlines a theoretical framework for four key data reuse scenarios. This practical guide was extracted from research papers, and consultation with stakeholders and the research community.
With Health Data Australia, researchers can explore descriptions of data from our publishing partners, identify relevant datasets, and request access. These requests will then be forwarded to the data owner for review.
To start requesting data, simply login with your AAF account.